Adagene Inc.
ADAG$180M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaJIANGSU138 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 31, 2026
33wMarket Overview
Stock performance and key metrics
ADAG News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ADG126 Mono | Phase 2 | Advanced/Metastatic Solid Tumors | - | - |
ADG126 | Phase 2 | Advanced/Metastatic Solid Tumors | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply